1270. Early Real-world Evidence in the Use of Eravacycline for the Management of Draconian Infections

BACKGROUND: Eravacycline (ERV) is a next-generation tetracycline approved for complicated intra-abdominal infections (cIAI) with in-vitro activity to multidrug-resistant organisms such as carbapenem resistant Enterobacteriaceae, extended spectrum beta-lactamase, and carbapenem-resistant Acinetobacte...

Descripción completa

Detalles Bibliográficos
Autores principales: Carr, Amy, El Ghali, Amer, Kaur, Parminder, Minor, Sarah B, Casapao, Anthony M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776886/
http://dx.doi.org/10.1093/ofid/ofaa439.1454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776886/
http://dx.doi.org/10.1093/ofid/ofaa439.1454

Ejemplares similares